Monday, July 17, 2017 6:46:48 PM
Ku, That would be "k" on the list. Pick your issue for friend or foe, LOL.
It is not clear to me which factions are aligned with Ronin or were involved with Ronin's acquisition of an SEC >5% reportable position. It is also not clear to me what factions received support from or provided support to Ronin. Yet, Ronin has announced they are looking for retail investor support, including mine, in voting for an agenda at the ASM in October that would place his investor group leaders in charge of PPHM. My providing such support is not something I do without careful consideration of faction alignments. What are the Ronin affiliations?
Perhaps, more information will be revealed that helps reveal the hand of factions influencing what has been made known over the last week or two? For now, Ronin's focus on Avid value extract while suggesting that the PPHM proprietary tech no longer warrants funding has me nervous. That is a huge paradigm shift for those retail investors who have held or expanded their long position in PPHM for years. Yes, that is while experiencing those two reverse splits, through assignment of options and compensation and through Friday's announced extraction of statistically significant positive results showing Bavi value drawn out of the halted Phase 3 trial. I observe that Ronin may not have known of this newly announced Bavi value component when his letter to shareholders was released. Yet, he may have been very much aware of this or other Bavi success being indicated in trials before those highly unusual events suppressed their role in supporting PPHM technology commercialization. Yes, it does matter, to me at least.
Best wishes and IMO.
KT
It is not clear to me which factions are aligned with Ronin or were involved with Ronin's acquisition of an SEC >5% reportable position. It is also not clear to me what factions received support from or provided support to Ronin. Yet, Ronin has announced they are looking for retail investor support, including mine, in voting for an agenda at the ASM in October that would place his investor group leaders in charge of PPHM. My providing such support is not something I do without careful consideration of faction alignments. What are the Ronin affiliations?
Perhaps, more information will be revealed that helps reveal the hand of factions influencing what has been made known over the last week or two? For now, Ronin's focus on Avid value extract while suggesting that the PPHM proprietary tech no longer warrants funding has me nervous. That is a huge paradigm shift for those retail investors who have held or expanded their long position in PPHM for years. Yes, that is while experiencing those two reverse splits, through assignment of options and compensation and through Friday's announced extraction of statistically significant positive results showing Bavi value drawn out of the halted Phase 3 trial. I observe that Ronin may not have known of this newly announced Bavi value component when his letter to shareholders was released. Yet, he may have been very much aware of this or other Bavi success being indicated in trials before those highly unusual events suppressed their role in supporting PPHM technology commercialization. Yes, it does matter, to me at least.
Best wishes and IMO.
KT
